期刊文献+

溃疡性结肠炎患者粪便中Cal、MMP-9、MPO水平检测的临床研究 被引量:15

Clinical studies of detection of fecal calprotectin,matrix metalloproteinase 9,myeloperoxidase in ulcerative colitis
在线阅读 下载PDF
导出
摘要 目的探讨溃疡性结肠炎(UC)患者粪便中钙卫蛋白(Cal)、基质金属蛋白酶9(MMP-9)、髓过氧化物酶(MPO)水平检测的临床意义。方法选择UC患者和正常对照者各50例,测定UC患者和正常对照者粪便中Cal、MMP-9、MPO水平。结果 UC活动期患者粪便中Cal、MMP-9、MPO水平显著高于缓解期患者和正常对照者,UC患者活动期轻中重度各组粪便中Cal、MMP-9、MPO水平比较差异有统计学意义(P<0.05,P<0.01);UC患者粪便中Cal、MMP-9、MPO水平与DAI评分显著相关(P<0.05)。结论粪便中Cal、MMP-9、MPO水平可作为UC患者疾病活动性评估的指标。 Objective To investigate and discuss the clinical significance of detecting the level of fecal calprotectin (Cal),matrix metalloproteinase-9( MMP-9),myelo-peroxidase( MPO)in patients with ulcerative colitis( UC). Methods To measure the level of fecal Cal,MMP-9,MPO in 50 patients with UC before and after treatment,and the level in 50 healthy controls. Results The level of fecal Cal,MMP-9,MPO in active UC was significantly high-er than the level in remission UC and healthy controls;the difference of the level of fecal Cal,MMP-9,MPO in dif-ferent clinical severity groups of mild grade,moderate grade,severe grade was statistically significant(P 〈 0. 05,P〈 0. 01). The level of fecal Cal,MMP-9,MPO also showed significant correlation with DAI in UC(P 〈 0. 05). Conclusion The level of fecal Cal,MMP-9,MPO can be used as fecal makers for jurging activity in UC.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第6期847-849,854,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:1308085MH146) 杨森科学研究委员会中国分会研究基金(编号:2012JRCC消化02)
关键词 钙卫蛋白 基质金属蛋白酶 9 髓过氧化物酶 粪便 溃疡性结肠炎 calprotectin matrix metalloproteinase-9 myeloperoxidase fecal ulcerative colitis
  • 相关文献

参考文献3

二级参考文献60

  • 1高翔,胡品津,何瑶,廖山婴,彭穗,陈旻湖.炎症性肠病患者血清中自身抗体检测的临床意义[J].中华内科杂志,2005,44(6):428-430. 被引量:39
  • 2刘思德,姜泊,周殿元.放大内镜结合黏膜染色技术诊断溃疡性结肠炎——附116例放大内镜形态分析[J].现代消化及介入诊疗,2005,10(2):116-118. 被引量:9
  • 3李亚红,韩英,吴开春.炎症性肠病危险因素的流行病学调查研究[J].胃肠病学和肝病学杂志,2006,15(2):161-162. 被引量:19
  • 4[1]Hanauer SB.Inflammatory bowel disease:epidemiology,pathogenesis,and therapeutic opportunities.Inflamm Bowel Dis 2006; 12 Suppl 1:S3-S9
  • 5[2]Desai D,Faubion WA,Sandborn WJ.Review article:biological activity markers in inflammatory bowel disease.Aliment Pharmacol Ther 2007; 25:247-255
  • 6[3]von Roon AC,Karamountzos L,Purkayastha S,Reese GE,Darzi AW,Teare JP,Paraskeva P,Tekkis PP.Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.Am J Gastroenterol 2007;102:803-813
  • 7[4]Roseth AG,Aadland E,Grzyb K.Normalization of faecal calprotectin:a predictor of mucosal healing in patients with inflammatory bowel disease.Scand J Gastroenterol 2004; 39:1017-1020
  • 8[5]Saverymuttu SH,Camilleri M,Rees H,Lavender JP,Hodgson HJ,Chadwick VS.Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease.A comparison with colonoscopy,histology,and fecal indium 111-granulocyte excretion.Gastroenterology 1986; 90:1121-1128
  • 9[6]Johne B,Fagerhol MK,Lyberg T,Prydz H,Brandtzaeg P,Naess-Andresen CF,Dale I.Functional and clinical aspects of the myelomonocyte protein calprotectin.Mol Pathol 1997;50:113-123
  • 10[7]Langhorst J,Elsenbruch S,Mueller T,Rueffer A,Spahn G,Michalsen A,Dobos GJ.Comparison of 4 neutrophilderived proteins in feces as indicators of disease activity in ulcerative colitis.Inflamm Bowel Dis 2005; 11:1085-1091

共引文献695

同被引文献148

引证文献15

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部